Zymeworks (NASDAQ: ZYME) reported Q4 2023 earnings per share (EPS) of -$0.19, up 103.98% year over year. Total Zymeworks earnings for the quarter were -$14.48 million. In the same quarter last year, Zymeworks's earnings per share (EPS) was $4.77.
As of Q2 2024, Zymeworks's earnings has grown year over year. Zymeworks's earnings in the past year totalled -$118.67 million.
What was ZYME's revenue last quarter?
Zymeworks (NASDAQ: ZYME) reported Q4 2023 revenue of $16.93 million up 95.79% year over year. In the same quarter last year, Zymeworks's revenue was $402.49 million.
What was ZYME's revenue growth in the past year?
As of Q2 2024, Zymeworks's revenue has grown -81.57% year over year. This is 226.2 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Zymeworks's revenue in the past year totalled $76.01 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.